chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Is it normal to still not feel really great after having us a vaccine; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION COMPLICATION (Is it normal to still not feel really great after having us a vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Is it normal to still not feel really great after having us a vaccine). At the time of the report, VACCINATION COMPLICATION (Is it normal to still not feel really great after having us a vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment medication was not provided.
7-31-08 Child's left thigh was reddened, swollen and hot.  Referred to doc or ER.  8-01-08 thigh was worse and was teken to ER again and given Rx for Keflex.  8-04-08 mom reports the leg is better.
1 of 4 pts immunized w/in a 2 wk period from the same lot who exp an inject site react the size of a silver dollar; react consisted of erythema, swelling, & hot to touch; treated w/APAP & ATB for poss cellulitis; pt recovered;
Patient is experiencing nausea, headache, myalgias, and erythemia. Patient has been experiencing symptoms for past 48 hours.
Pt was given Pfizer Covid immunization (Lot EN6199) on 03-05-2021 and Moderna as second dose immunization (Lot: 041B21A) on 4/23/2021. Pt was made aware of this error.
Noted tongue very sore, diarrhea, wheezing, lip swelling and cracking, sneezing extreme fatigue, runny nose, extreme sore throat. Did not see MD took Benadryl on 1/4/13 and begin to improve. 1/6/13 client is greatly improved continue to take Benadryl when not working.
The pt developed a 3 x 2 inch tender, warm, erythema area at DTaP injection site.
Site: Pain at Injection Site-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: emt called transported to hospital-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Mild
Shoulder pain,  then chest pain,then chest pain with difficulty breathing,  then one week in the hospital
Within a couple of weeks daily headaches that could not be remedies by usual measures began.  Often times these headaches would proceed into all out debilitating migraines with nausea, vertigo and vision being affected accompanied by intense pain and pressure Also unusual, unaccountable origin bruising appeared on mostly legs, thighs a few small ones on arms.  Generally one sizable bruise each week, Prior person did not bruise easy or rarely.
Within 2 hrs of receiving vaccination, I became so dizzy. I had trouble standing in 3 hrs, I was vomiting, diarrhea. Within two hours of receiving the vaccination, I first noticed my throat felt like it as going to become sore, then I became dizzy, very light headed and sick to my stomach. Within the third hour I had a bad headache and was vomiting and having diarrhea and severe chills. I then knew enough to start drinking water as much as possible and I took PEPTO to easy the stomach distress. This went on well in to late hours that same day. I had to get up 3 more time that night with vomiting and diarrhea. The next day left weak and very sore in the stomach and painful joints  in the legs, shoulders and neck. The main reason for sending this information to you is: this is now 4 days later and I am still having diarrhea, joint pain as well as stomach distress. These symptoms are not as severe but nevertheless they are still with me.
vaccine received 8/15/20 and side effects started 8/16/20 including warmth, redness, swelling, pain and itching localized to the entire upper left arm. Seen in our clinic 8/18/20. Advised to ice the area and seek immediate medical attention for any respiratory distress.
Severe pain in arm & limited movement, more-so than normal from injection.  Took 5 weeks before I could use arm with no pain after 1st shot.  Got 2nd injection on July 3 - severe pain once more that is still with me today, December 3, 2021 !  Unable to use arm fully without severe pain, cannot sleep on Right side at all and arm feels hot most times.
lost sense of taste; lost sense of taste smell; cough; no appetite; weak; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (lost sense of taste), ANOSMIA (lost sense of taste smell), COUGH (cough), DECREASED APPETITE (no appetite) and ASTHENIA (weak) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced AGEUSIA (lost sense of taste), ANOSMIA (lost sense of taste smell), COUGH (cough), DECREASED APPETITE (no appetite) and ASTHENIA (weak). At the time of the report, AGEUSIA (lost sense of taste), ANOSMIA (lost sense of taste smell), COUGH (cough), DECREASED APPETITE (no appetite) and ASTHENIA (weak) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  No treatment medication were provided.    This case was linked to MOD-2021-395985 (Patient Link).
Nausea, vomiting, chill, headache. Lasted more than 2hrs. Taken to ED and treated for nausea and rehydrated.
exacerbation of psoriatic eczema outbreak to include bilateral upper and lower extremities, all of back, abdomen and chest, buttocks, eyebrows, scalp and hair line. Increased itching that is unrelieved by any cream/lotion to include triamcinolone. Hair loss to include large clumps after washing and increased shedding when dry and/or brushing.
Had steroid indfusions. Now oral steroid. MRI pending of back and head. Following up with neruology.  Lab work up negative.
Vaccine frozen rather than refrigerated. Dose administered. Offered revaccination. Had bivalent since this vaccine
Information has been received from a nurse practitioner (also reported as a pharmacist) concerning a patient who was vaccinated with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) but it was intended that they receive zoster vaccine live (Oka/Merck). A product quality complaint was not involved. No further information is available.
Approximately 15 minutes after receiving the first dose of the vaccine, my face became tingly/numb around my cheeks and mouth. No swelling occurred and there was no hinderance to my breathing. Upon leaving the vaccination site and arriving home, I took a Benadryl which alleviated my symptom within 30 minutes.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Jan2021 as dose 1, single (Lot number: el9265), on 23Feb2021 as dose 2, single (Lot number: en6198), on 22Aug2021 as dose 3 (booster), single (Lot number: fc3180) and on 16May2022 as dose 4 (booster), single (Lot number: fk9893) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history included: "multiple myeloma" (unspecified if ongoing). Patient has no known allergies. Concomitant medication(s) included: LENALIDOMIDE, start date: 27Sep2015; ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID], start date: 27Sep2015; CALCIUM CARBONATE WITH D3, start date: 01Jan2010. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Sep2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Sep2022) Positive, notes: Recurrent positive COVID test. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid treatment from 03Sep2022 to 08Sep2022.
Cellulitis due to vaccine on affected area ((L) deltoid). KEFLEX 250/5 1 tsp PO TID # 75cc. MOTRIN 1 1/2 tsp PO q 6 hours.
Client received 2nd COVID vaccine on 05/10/2021 at 3pm, 3 days later adverse reaction began of swollen lymph nodes.  Two weeks later the swelling went away.  The injection site took a month to heal from having swelling.  At this time client report he is having weird reactions to bug bites that is causing him to take up to one week to heal from the bites.  Client lymph nodes have again began to swell under both armpits, they feel tender to touch.  Client has not seen a medical provider for adverse reaction.
PATIENT WAS VACCINATED ON 01/21/2022. PATIENT WITH A SECOND DOSE ADMINISTERED ON 12/06/2021 AND THE REINFORCEMENT WAS ADMINISTERED BEFORE 5 MONTHS. A FAMILY MEMBER WAS CALLED TO VERIFY THE MINOR'S HEALTH STATUS.
Patient had no outstanding medical history but anxiety. Per her husband, patient rapidly declined since receiving the first dose of Moderna COVID19 vaccine on 9/2/21. Patient was seen falling to the ground and having a "seizure" and then becoming unresponsive on 9/14/21. EMS found the patient to be in ventricular fibrillation cardiac arrest. Patient was brought to ED with CPR in progress. At ED, 45 minutes of resuscitative effort was done without ROSC. Time of death called at 1504.
moderate to severe muscle tightness in the areas along my back, shoulders and neck. started on the morning after the shot taken and has continued up to now. I go to the Clinic and Specialty Clinic for my medical needs.
pt recvd vax & 3 hrs p/vax exp h/a, nausea, vomiting, malaise;
First dose was given on 13Mar2020 / second dose had not been given yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 13th March 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional case details were reported as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of vaccine, which led to incomplete course of vaccination. The reporter called for information regarding the completion of the dosing schedule for the Shingrix vaccine. The reporter did not have complete patient or vaccine information but could find it if enough time was available. The reporter consented to follow up by mail.
At 12:05 am client came to the staff office treatment facility stating he feels sick and has been throwing up. He stated he had the Johnson & Johnson vaccine Tuesday 4/6/21 in the morning and around 6 pm on Tuesday he started to feel sick.  The staff took his temperature and it was 100.9 degrees.  The client was dry heaving and red in the face and having cold sweats.  Staff monitored him while 911 was called and paramedics showed up within 10 minutes.  The Program Manager was notified and the client was given instructions for when going to the hospital.
This spontaneous report was received from a healthcare worker regarding unspecified number of patients of unknown age and gender. The medical history of patients and their concurrent conditions were not reported. On an unknown date, multiple unspecified patients were administered with improperly stored doses of PROQUAD (Merck) (lot # L023113, expiry date 24-DEC-2016 and lot # K020748, expiry date 30-APR-2016) dose, route unknown. Concomitant medications were not reported. During the storage the vaccine was exposed to temperature of 70 degrees F for a time frame of 60 hours and later the storage temperature was back in range. It was reported there was previous temperature excursion where the same vaccine was exposed to -11.9 degrees C for 44 hours on 14-DEC-2015. No adverse effects were reported. Product quality complaint (PQC) was not filed. This is one of the three reports received from the same reporter. Additional information has been requested.
Severe body ache; muscle pain throughout entire body; Nausea; headaches; difficulty walking; booster; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER COVID-19 VACCINE), at the age of 66 years old, dose 3 via an unspecified route of administration in right arm on 25Oct2021 at 16:00 (Lot Number: FE3590) as dose 3 (booster), single for COVID-19 immunisation. Patient was not pregnant. Patient was not diagnosed with COVID-19 prior vaccination. Patient had not been tested for COVID-19 post vaccination. Medical history included fibromyalgia, known allergies to sulfites, wheat, strawberries, mold. The patient did not receive other vaccine in four weeks. Concomitant medications in two weeks included prescribed medications. Historical vaccine included BNT162B2, dose 1 (Lot Number: EN6201) on 23Feb2021 at 11:00 and dose 2 (Lot Number: EN6207) on 17Mar2021 at 13:00, both at the age of 65 years old, in right arm as single dose for COVID-19 immunisation. The patient previously took morphine, erythromycin and experienced known allergies. The patient experienced severe body ache and muscle pain throughout entire body, nausea, headaches and difficulty walking on 25Oct2021 at 18:00. Events resulted in doctor or other healthcare professional office/clinic visit, disability or permanent damage. Therapeutic measures were taken as a result of events and included treatment with increase in pain medication. Outcome of event booster was unknown, of other events was not recovered.
Dizziness within 15 minutes, heart pounding a few hours later, gone by next day. Tolerated next dose with no symptoms.
Bradycardia,Dusky color and nonresponsive,on the evening after having received vaccines that morning.  Treated in local ER, with good recovery, and subsequently transferred to another hospital for further observation.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 60-year-old female patient who received SHINGRIX for prophylaxis. On 27th June 2018, the patient received SHINGRIX (intramuscular) 50 mcg/mg. On 27th June 2018, immediately after receiving SHINGRIX, the patient experienced injection site pain, pain and pain in arm. On 28th June 2018, the patient experienced headache, extremities hot feeling of, erythema of extremities, swelling arm and feeling bad. The patient was treated with non-drug therapy (Ice Pack (No Medication)). On 30th June 2018, the outcome of the headache, pain and feeling bad were recovered/resolved. On an unknown date, the outcome of the injection site pain, extremities hot feeling of, erythema of extremities, swelling arm and pain in arm were not recovered/not resolved. It was unknown if the reporter considered the injection site pain, headache, extremities hot feeling of, erythema of extremities, swelling arm, pain, pain in arm and feeling bad to be related to SHINGRIX. Additional details were provided as follow:Wednesday, the patient experienced pain when given the SHINGRIX and on the same day in afternoon several hours after receiving SHINGRIX, her arm was sore for the remainder of the day. Less than a day after receiving SHINGRIX, the patient developed aches. On 28th June 2018 Thursday, 1 day after receiving SHINGRIX, when the patient awoke, she felt bad all over and in night she developed a severe headache and experienced swelling and redness on her arm and was hot to touch. On 29th June 2018 Saturday, when the patient awoke in morning, she felt better except her sore arm. The patient's husband actually noticed the swelling and redness on her arm. By Saturday night it had worsened but all other symptoms resolved. The patient's arm was redder and really hot to the touch and the area was much larger. Sunday morning it felt better but by that evening, it was larger and worse than on Saturday evening. As of today in the reporting date, it was not better. On 30th June 2018, in afternoon, the patient consulted with her pharmacist, who told her to put ice on it which did not help. Then on Saturday night the patient called a nurse who told her to put a warm compress on it.
Approx 10 days p/MMR pt devel fever 102-103, stiff neck, & swelling lt parotid area; Taken to MD day p/sx devel & advised to give APAP for elevated temp & discomfort; Condition resolved in 3-4 days;
Woke up feeling cold and chills and violent shakes lasting about 45 minutes. Client went to emergency room.
Excruciating rotating joint pain which lasted for weeks. (elbows, Wrists, knee,.) Neck rigid very painful.  generally feeling not well, bottom number of blood pressure elevated for weeks ,  swollen glands in neck, weeks of exhaustion.
Itchy (rash); Painful rash; This non-serious case was reported by a other health professional via call center representative and described the occurrence of itchy rash in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number 5YP3L, expiry date 31-JAN-2026) for prophylaxis.   On 10-AUG-2023 15:00, the patient received the 1st dose of Bexsero. On 11-AUG-2023 15:00, 1 days after receiving Bexsero, the patient experienced itchy rash (Verbatim: Itchy (rash)). In AUG-2023, the patient experienced pain (Verbatim: Painful rash). The outcome of the itchy rash was resolving and the outcome of the pain was resolved.   It was unknown if the reporter considered the itchy rash and pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   It was unknown if the company considered the itchy rash and pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-AUG-2023 The reporter sated that a patient experienced a rash all over the body after the administration of Bexsero.  The rash developed later that day or the next day. The reporter stated that the patient called yesterday and reported that was patient was feeling better and the rash was not itchy or painful anymore. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up via postal.
Pt received Tdap in Rt deltoid on 7/24/09. I received a call from his mom on 7/27/09 stating that over the weekend around the inj. site it became red, swollen, warm and appeared to have hives around the site. After giving him BENADRYL, his symptoms went away.
Already taking Pepcid, Benadryl, Prednisone x 48 hrs. prior to vaccine administration. Within 1 hour exhibited symptoms consistent with anaphylaxis. Initial symptoms were:  chest pain, tachycardia, hives on neck and chest (within the few hours the Benadryl had worn off). Itching, swelling of the face and neck, injection site pain and redness, tiredness, headache, muscle pain, chills, joint pain especially in neck and hips, flushing of torso, face, and neck, bilateral ear pain > on right, cervical lymphnodenopathy, nasuea, diarrhea, feeling unwell. Continued prednisone for a few days and Benadryl for 1 week. On 08/19/2021 at 11:00 saw Allergist for persistant symptoms,placed on prednisone.
Dose drew and administered from vile that had been sitting out at room temperature for longer than the recommended time frame by the CDC.  Patient experienced symptoms of soreness at injection site, neck pain on left side, low grade fever and body aches within 24 hours of vaccination.
1 pm was vaccine admin time on Wed (1/20). By 8 pm, her arm was very sore & with significant fatigue. 1am that night, awoke with chills, fever (102), generalized muscle aches. By midday Thursday, these symptoms began to dissipate slightly and she developed a h/a.  Friday, fever, chills, h/a were gone & nausea and abdominal pain started. No vomiting or diarrhea occurred.  By SAturday evening, nausea improved but upper legs became tremulous and weak.  Weak, tremulous legs have continued and persist up until today (monday, 1/25).
I developed a lump on the side of my neck. It was not painful, but I noticed it. I contacted my family doctor and had an Ultrasound on September 22, 2022. It showed 4 abnormal lymph nodes in the right side of my neck. I went to a radiologist who completed needle biopsy and sent the results to an oncologist. He got the result that it was Hodgkin's. I am going in November 221, to have the lymph node removed and hopefully have enough samples to properly classify it as Hodgkin's. I also had a pet scan done on November 03, 2022, and it showed the only lymph nodes that were involved were in my neck.
pt recvd vax 19JUL95 & 21JUL95 c/o pain @ inj site; site appeared reddened;no fever;no cellulitis;
Pt c/o arm pain so severe she could not take off her shirt. Arm is swollen and hard near injection site. Pt. afebrile. Pt taking OTC ibuprofen with minimal relief. Advised pt ibuprofen PRN pain, cool compress to affected area. Urgent care advised for exacerbation of sx's.
Developed fatigue, chills, muscle aches, injection site pain 16 hours post-vaccination. lasted for 12 hours,  symptoms resolved with one dose of Tylenol.
the patients guardian signed off that the patient was 18 and eligible for a booster, after giving the booster shot it came to our attention that the patient was 17 years old and not eligible for a booster
Pt complained that she had insomnia that night after the shot. She also experienced diarrhea, nausea, stomach cramps, headaches, muscle ache, fatigue. She could not sleep that evening. She needed to take TYLENOL PM to help with insomnia and pain.  She also mentioned that the 1st shot was worst and this 2nd shot was not as bad as the symptoms experienced in the 1st shot. She did not report of adverse effects after the 1st shot. But after getting 2nd shot, she remembered the effects of the 1st shot.
Vaccine DTaP given Lt by 7-12-07 ER visit 7-13-07 red swollen warm Augmentin 400 mg/5 ml 5 ml BID x 10 days
Irregular period, poly cystic ovary syndrome, hair loss, headache, fatigue, nausea and stiffness